AFC-HD AMS Life Science Co. Ltd. (2927.TO) | ||
Japan | ||
Year Ended August 31 | ||
GROUP | 2024 | 2023 |
Revenue | Y30.19 bln | Y25.58 bln |
Operating Profit | Y1.92 bln | Y1.64 bln |
Pretax Profit | Y1.92 bln | Y1.65 bln |
Net Profit | Y1.25 bln | Y1.10 bln |
Per share | ||
Earnings | Y89.20 | Y78.51 |
Diluted Earnings | Y89.11 | Y78.46 |
Results are based on Japanese accounting standards. |
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(MORE TO FOLLOW) Dow Jones Newswires
November 08, 2024 01:31 ET (06:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。